Mitosis, Cytoskeleton Regulation, and Drug Resistance in Receptor Triple Negative Breast Cancer
Alexandre Matov

TL;DR
This study investigates the unique microtubule dynamics and spindle behaviors in aggressive triple-negative breast cancer cells, identifying potential therapeutic targets by analyzing spindle mechanics and proposing optimal tubulin inhibitors.
Contribution
It reveals abnormal spindle oscillations and rapid microtubule polymerization in TNBC cells, suggesting disrupted spindle positioning as a therapeutic target and proposing a strategy for selecting tubulin inhibitors.
Findings
MDA-MB-231 cells show largest spindles and rapid spindle twisting.
High microtubule polymerization rates are linked to tumor aggressiveness.
Proposed strategy for selecting tubulin inhibitors based on microtubule dynamics.
Abstract
During cell division, the receptor triple-negative MDA-MB-231 mitotic spindles are the largest in comparison to other BC cell lines. Many of the MDA-MB-231 spindles exhibit rapid lateral twisting during metaphase, which remains unaffected by knockdown of the oncogene Myc and treatment with inhibitors of the serine/threonine-protein kinase B-Raf and the epidermal growth factor receptor (EGFR), alone or in any combination. The MDA-MB-231 cells are the most aggressive and rapidly form metastatic tumors in xenograft transplant models, and exhibited very high proliferation rates when plated as three-dimensional cultures in Matrigel. Quantitative image analysis of microtubules (MTs) in six BC cell lines - MDA-MB-231 (receptor negative), HCC-1143 (receptor negative), HCC-3153 (receptor negative), ZR75B (estrogen receptor-positive), LY2 (progesterone receptor-positive), HCC-1428 (estrogen…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEstrogen and related hormone effects · HER2/EGFR in Cancer Research · Cancer Treatment and Pharmacology
MethodsMatching The Statements
